Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Berl Munch Tierarztl Wochenschr ; 119(11-12): 461-6, 2006.
Artigo em Alemão | MEDLINE | ID: mdl-17172133

RESUMO

In Germany, the program for controlling salmonella infections in pigs is based on tests detecting salmonella-lipopolysaccharide (LPS) induced antibodies in meat-juice or blood. These conventional tests which are based on the technology of enzyme-linked immunosorbent assay (ELISA) detect exclusively or mainly immunoglobulin(lg)G antibodies. Meanwhile, novel ELISA systems (WCE-ELISA, 3-Isotype-Screening-ELISA) have been developed, which additionally detect the antibody classes IgM and IgA.This fact enables the registration of fresh salmonella infections (starting with day 5 p.i.) and thus, the distinction between early and older infections. The results show that animals with early salmonella infections appear significantly more often in herds with a high than with a low prevalence. With the newly developed tests this group of animals can be detected much more efficiently and precisely than with the tests used so far. Due to their clearly improved sensitivity the application of the WCE-ELISA and the 3-Isotype-Screening-ELISA in terms of the QS-Salmonella-Monitoring program can therefore significantly improve the selection of farms with potential salmonella excretors. Additionally, the WCE-ELISA can be applied very suitable for the examination of individual animals.


Assuntos
Anticorpos Antibacterianos/análise , Ensaio de Imunoadsorção Enzimática/veterinária , Isotipos de Imunoglobulinas/análise , Salmonelose Animal/diagnóstico , Salmonella/imunologia , Doenças dos Suínos/diagnóstico , Animais , Ensaio de Imunoadsorção Enzimática/métodos , Imunoglobulina A/análise , Imunoglobulina G/análise , Imunoglobulina M/análise , Salmonelose Animal/epidemiologia , Sensibilidade e Especificidade , Suínos , Doenças dos Suínos/epidemiologia
2.
J Hepatol ; 44(6): 1017-25, 2006 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-16469406

RESUMO

BACKGROUND/AIMS: Four different ribozymes (Rz) targeting the hepatitis C virus (HCV) 5'-non-coding region (NCR) at nucleotide (nt) positions GUA 165 (Rz1), GUC 270 (Rz2), GUA 330 (Rz3) and GCA 348 (Rz1293) were compared for in vitro cleavage using a 455 nt HCV RNA substrate. The GUA 330 (Rz3) and GCA 348 (Rz1293) ribozymes, both targeting the HCV loop IV region, were found to be the most efficient, and were further analyzed in an in vitro translation system. METHODS: For this purpose RNA transcribed from a construct encoding a HCV-5'-NCR-luciferase fusion protein was used. Cleavage-inactive (Rz1426), mismatch (Rz1293m) or unrelated ribozymes (Rz1437) were synthesized as controls for Rz-1293. HCV specificity was analysed by competition experiments using sense and mismatch oligodeoxynucleotides HCVrzCI and HCVrzMM, respectively. RESULTS: A chemically modified nuclease-resistant variant of the GCA 348 cleaving ribozyme was selected for cell culture experiments using recombinant HepG2 or CCL13 cell lines stably transfected with a HCV-5'-NCR-luciferase target construct. CONCLUSIONS: This ribozyme (Rz1293) showed an inhibitory activity of translation of more than 70% thus verifying that the GCA 348 cleavage site in the HCV loop IV is an accessible target site in vivo and may be suitable for the development of novel optimized hammerhead structures.


Assuntos
Antivirais/farmacologia , Hepacivirus/efeitos dos fármacos , RNA Catalítico/farmacologia , RNA Viral/efeitos dos fármacos , Regiões não Traduzidas/efeitos dos fármacos , Células Cultivadas , Humanos , Conformação de Ácido Nucleico , Biossíntese de Proteínas/efeitos dos fármacos , Replicação Viral/efeitos dos fármacos
3.
Digestion ; 68(1): 13-23, 2003.
Artigo em Inglês | MEDLINE | ID: mdl-12949435

RESUMO

BACKGROUND AND AIMS: Adeno-associated virus (AAV) is the only known virus capable of site-specific genomic integration in human cells. Thus, AAV-based vectors may be an attractive option to achieve prolonged transgene expression in human cells. We therefore studied the minimal elements of gene therapy vectors necessary for stable integration and tested the effectiveness of this approach in hepatoma cells. METHODS: Plasmids were constructed that contained a GFPneo fusion transgene with or without the AAV-inverted terminal repeats (ITRs). In addition, Rep protein was either encoded in CIS or supplied in TRANS by co-transfections. Stable clones were analyzed by Southern blotting for site-specific integration. RESULTS: The ITRs alone conferred neither stable nor site-specific transgene integration. Expression of Rep protein in CIS or TRANS resulted in an increased frequency of integration regardless of the presence of ITRs. It was shown that in the absence of the ITRs, other Rep-binding site (RBS) like sequences such as the ColE1 sequence present in plasmid backbones can function as RBS. Site-specific integration was achieved in up to 26% of clones derived from hepatoma cells. CONCLUSION: Both expression of Rep proteins and inclusion of a RBS are necessary for enhanced and stable integration of AAV-based non-viral vectors. A novel two-plasmid system capable of achieving stable and site-specific gene transfer in hepatoma cells is introduced.


Assuntos
Carcinoma Hepatocelular/patologia , Proteínas de Ligação a DNA/metabolismo , Dependovirus , Técnicas de Transferência de Genes , Neoplasias Hepáticas/patologia , Proteínas Virais/metabolismo , Cromossomos Humanos Par 19 , Vetores Genéticos , Humanos , Plasmídeos , Sequências Repetidas Terminais , Células Tumorais Cultivadas
4.
J Gen Virol ; 80 ( Pt 10): 2673-2683, 1999 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-10573160

RESUMO

Hepatitis B virus (HBV) has a double-stranded DNA genome. The minus-strand contains coding regions for all known HBV proteins and most of the cis-regulatory elements. Little is known about transcription from the S-(+)-strand and its regulation. Thus, the presence of regulatory elements located on the S-(+)-strand was investigated by inserting nt 1038-1783 of HBV in both orientations between the human cytomegalovirus (HCMV) promoter and a luciferase gene. Transfection experiments revealed that the plasmid containing this HBV DNA fragment in an orientation allowing expression from the S-(+)-strand (antisense) led to inhibition of luciferase gene expression compared to the plasmid containing this sequence in an orientation that allows gene expression from the L-(-)-strand (sense). Deletion analyses delimit the sequence essential for the inhibitory effect to a 150 bp region that also carries part of the enhancerII/core promoter complex. However, the possible influence of this regulatory element has been excluded in various experiments. The repressing HBV sequence acts in an orientation- and position-dependent manner; no inhibition was observed when this DNA element was inserted upstream of the HCMV promoter or downstream of the luciferase gene. Northern blot analyses revealed reduced luciferase mRNA steady-state levels in cells transfected with constructs containing the essential HBV sequence in antisense orientation compared to plasmids containing this sequence in sense orientation. Since nuclear run-on experiments showed similar transcription initiation rates with these plasmids, the diminished luciferase mRNA steady-state levels must be due to altered stabilities, suggesting that nt 1783-1638 of HBV encode an RNA-destabilizing element.


Assuntos
DNA Viral , Regulação Viral da Expressão Gênica , Vírus da Hepatite B/genética , Sequências Reguladoras de Ácido Nucleico , DNA de Cadeia Simples , Células HeLa , Humanos , RNA Mensageiro , Deleção de Sequência , Células Tumorais Cultivadas
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...